Eradicating a virus from the community requires everyone to have access to prevention, as is the case with tuberculosis. So why not HIV?
A global-first, UNSW-led trial of an HIV prevention medication has resulted in an almost one-third decline in infections in the large-scale target group.
An increase in condomless sex in pre-exposure prophylaxis users is predictable as preventing HIV is the key motivator for condom use among gay and bisexual men.
Proposed changes to Victoria's drug laws and policies have potential but fall short in some key areas.
A recommendation that the HIV prevention drug PrEP be approved for public subsidy has been hailed as an essential step in Australia's response to HIV.
PNG's first representative survey of people most at risk for HIV has revealed that one in six sex workers in Port Moresby are HIV positive.
New data released by the Kirby Centre shows a sharp increase in the diagnosis of gonorrhoea and a widening gap in HIV infection rates between Indigenous and non-Indigenous people.
The latest report by UNSW’s Centre for Social Research in Health shows increasing use of HIV medications to prevent the spread of HIV by gay and bisexual men.
Australia’s annual report card on STIs and blood-borne viruses finds that gonorrhoea has increased by 63% over the past five years.
Reviews of the global prevalence of injecting drug use and of interventions to prevent the spread of blood-borne viruses among people who inject drugs paint a worrying picture.